SO
PACB icon

STRS Ohio’s Pacific Biosciences PACB Stock Holding History

STRS Ohio’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-51,000
Closed -$500K – 2005
2023
Q4 		$500K Sell
51,000
-9,500
-16% -$77.7K ﹤0.01% 1289
2023
Q3 		$505K Sell
60,500
-29,700
-33% -$339K ﹤0.01% 1259
2023
Q2 		$1.2M Sell
90,200
-1,900
-2% -$23.1K 0.01% 861
2023
Q1 		$1.07M Buy
92,100
+64,700
+236% +$643K ﹤0.01% 908
2022
Q4 		$224K Buy
27,400
+24,500
+845% +$211K ﹤0.01% 1565
2022
Q3 		$16K Buy
+2,900
New +$16.6K ﹤0.01% 1944
2022
Q1 		– Sell
-13,200
Closed -$270K – 2221
2021
Q4 		$270K Sell
13,200
-7,400
-36% -$179K ﹤0.01% 1649
2021
Q3 		$526K Sell
20,600
-13,400
-39% -$397K ﹤0.01% 1488
2021
Q2 		$1.19M Sell
34,000
-31,100
-48% -$905K ﹤0.01% 1067
2021
Q1 		$2.17M Sell
65,100
-6,700
-9% -$235K 0.01% 689
2020
Q4 		$1.86M Sell
71,800
-16,000
-18% -$272K 0.01% 733
2020
Q3 		$866K Buy
87,800
+62,500
+247% +$360K ﹤0.01% 998
2020
Q2 		$87K Buy
+25,300
New +$86.1K ﹤0.01% 1819
2019
Q3 		– Sell
-47,300
Closed -$286K – 2135
2019
Q2 		$286K Buy
47,300
+3,300
+8% +$23.1K ﹤0.01% 1598
2019
Q1 		$318K Hold
44,000
– – ﹤0.01% 1519
2018
Q4 		$325K Buy
+44,000
New +$279K ﹤0.01% 1471
2016
Q3 		– Sell
-18,200
Closed -$152K – 1941
2016
Q2 		$128K Sell
18,200
-26,000
-59% -$238K ﹤0.01% 1654
2016
Q1 		$375K Sell
44,200
-2,900
-6% -$28.5K ﹤0.01% 1372
2015
Q4 		$618K Sell
47,100
-109,900
-70% -$986K ﹤0.01% 1164
2015
Q3 		$574K Buy
157,000
+21,300
+16% +$104K ﹤0.01% 1209
2015
Q2 		$781K Buy
135,700
+6,400
+5% +$37K ﹤0.01% 1048
2015
Q1 		$755K Buy
129,300
+78,657
+155% +$542K ﹤0.01% 976
2014
Q4 		$397K Buy
50,643
+143
+0.3% +$915 ﹤0.01% 1267
2014
Q3 		$248K Buy
50,500
+33,200
+192% +$174K ﹤0.01% 1413
2014
Q2 		$107K Buy
17,300
+14,200
+458% +$71.1K ﹤0.01% 1541
2014
Q1 		$17K Buy
+3,100
New +$19.6K ﹤0.01% 1685

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.39B AUM 10.34% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

STRS Ohio's PACB Position: Q1 2024 in Review

STRS Ohio sold out of Pacific Biosciences (PACB) in Q1 2024, closing a stake of 51,000 shares — an estimated $500K sold.

STRS Ohio first reported a position in PACB in Q1 2014 and held it in 26 quarters. The position peaked at $2.17M in Q1 2021. 268 funds tracked by Wall St. Rank hold PACB as of Q1 2024.

  • STRS Ohio reported no remaining Pacific Biosciences position as of Q1 2024 after selling out during the quarter.
  • STRS Ohio sold 51,000 Pacific Biosciences shares in Q1 2024, an estimated $500K.
  • STRS Ohio first reported a position in Pacific Biosciences in Q1 2014 and held it in 26 quarters.
  • STRS Ohio's Pacific Biosciences position peaked at $2.17M in Q1 2021.
  • 268 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2024.

Based on STRS Ohio's 13F filing for Q1 2024, filed 13 May 2024.